SCHEMBL6942019

SCHEMBL6942019

CCOC(=O)N(C)CCc1ccc(O)c(O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.53
HSD17B10 Q99714 2/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
DRD2 P14416 1/20 0.53
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
DRD1 P21728 1/20 0.53
DRD4 P21917 1/20 0.53
DRD5 P21918 1/20 0.53
ADRA1D P25100 1/20 0.53
ADRA1A P35348 1/20 0.53
ADRA1B P35368 1/20 0.53
DRD3 P35462 1/20 0.53
KDM4E B2RXH2 3/20 0.51
PMP22 Q01453 1/20 0.51
IAPP P10997 3/20 0.49
YWHAG P61981 1/20 0.47
APP P05067 1/20 0.47
CA12 O43570 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10603208 0.83 APP (0.50) HIF1AHSD17B10CYP3A4CYP2D6DRD2
SCHEMBL6938226 0.79 TRPV1 (0.49) HIF1AHSD17B10CYP3A4CYP2D6DRD2
SCHEMBL13034052 0.78 LTB4R (0.52) HSD17B10ALDH1A1MAPTLMNAALOX5
SCHEMBL11172152 0.76 NAMPT (0.45) CYP3A4CYP2D6ALDH1A1MAPTLMNA
SCHEMBL25132513 0.75 ALOX15 (0.50) HIF1AHSD17B10CYP3A4CYP2D6DRD2
SCHEMBL26491296 0.75 HIF1A (0.51) HIF1AHSD17B10CYP3A4CYP2D6DRD2
SCHEMBL30291871 0.75 APP (0.73) HIF1AHSD17B10KDM4EIAPPYWHAG
SCHEMBL490911 0.75 APP (0.73) HIF1AHSD17B10KDM4EIAPPYWHAG
SCHEMBL30364339 0.75 HIF1A (0.50) HIF1AHSD17B10CYP3A4CYP2D6DRD2
SCHEMBL67764 0.73 HIF1A (0.65) HIF1AHSD17B10CYP3A4CYP2D6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069307-A1 2-(3,4-Dihydroxyphenyl)ethyl-substituted carbonic acid derivatives and their use HAARMANN & REIMER GMBH (DE) 2003-04-10 US disclosed
EP-1284145-A1 2-(3,4-Dihydroxyphenyl)ethyl substituted carbonic acid derivatives and their use HAARMANN & REIMER GMBH (DE) 2003-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069307-A1 2-(3,4-Dihydroxyphenyl)ethyl-substituted carbonic acid derivatives and their use NFE2L2, AGER, ME2 HIF1A 126/4885HSD17B10 1254/4885CYP3A4 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.